About

Evaluate radically transforms your confidence in strategic portfolio decisions. We are the leading provider of commercial intelligence and predictive analytics for the global pharmaceutical industry. We work with the world’s largest pharmaceutical corporations, financial services firms, management consultancies and service providers, as well as a wide range of innovative biotech and medtech companies. From an overview of the broader market to a detailed product or company analysis, Evaluate's integrated platform is designed to take you from exploration to full understanding as quickly and accurately as possible. We help you: - Identify competitor developments and likely time to market - Forecast patient populations and product sales for a potential lead asset - Undertake NPV assessments based on modelling discounted cash flows - Manage clinical trial costing Evaluate offers a pharmaceutical Consulting & Analytics service designed to help clients address unique scientific, clinical and commercial challenges. Our pharmaceutical consulting services provide insight into: - Market Analysis & Competitor Intelligence - Corporate Strategy & Franchise Planning - Market Expansion & Forecasting - Mergers & Acquisition - New Product Development - Market Access and Pricing - Commercialization Evaluate is now a Norstella company: an organization that helps to ease and accelerate patient access to life-changing therapies. About Evaluate Evaluate radically transforms your confidence in strategic portfolio decisions. In biopharma, making the right decisions has an incredible impact on patients’ lives. Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines. Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real world data, and deep expertise to help you make portfolio decisions that drive growth. About Evaluate Evaluate radically transforms your confidence in strategic portfolio decisions. In biopharma, making the right decisions has an incredible impact on patients’ lives. Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines. Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real world data, and deep expertise to help you make portfolio decisions that drive growth. Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate’s solutions give you the time and confidence to turn understanding into insight, and insight into action. Market Sizing & Forecasting: Evaluate’s suite of forecasting solutions enables you to make confident investment, partnering, and commercial decisions. Gold-standard consensus forecasts provide an unmatched view into your markets, while custom forecast models, and proprietary analogs enable you to develop informed forecasts on your key assets. The result? A comprehensive view of the market – and your place in it. Business Development & Licensing: Every deal is different and requires a clear view of potential partners, comparable deals, and market potential. To support you, we go beyond asset assessment. Our solutions provide a systematic approach to enable you to compare candidates based on commercial, clinical, and scientific criteria such as market novelty, potential revenue, competitive intensity, and partner suitability. Portfolio Optimization & Asset Strategy: In an ever-evolving market landscape, you must understand the intricacies of clinical and commercial differentiation. Our comprehensive suite of solutions and insights give you the competitive edge you need to navigate the market’s complexities, optimize your pipeline, develop comprehensive scenario planning, and prioritize the right indications. Competitive Intelligence: For biotech and pharma companies alike, a comprehensive view of the competitive landscape is vital. Evaluate’s blend of data-driven solutions and expert analysis provide real-time tracking, analysis, and strategic intelligence to support decision-making processes across drug development, manufacturing, and market competition. So nothing need take you by surprise. Consulting & Analytics: Evaluate’s custom analytics team help you to address unique commercial challenges. We answer key asset, portfolio, and corporate strategy-related questions, powered by the combined resources of Norstella. With access to extensive data assets and experience across therapy areas and modalities, we partner with you to provide the answers you need to drive success.